OraSure Technologies 将来の成長

Future 基準チェック /06

OraSure Technologiesの収益と利益は、それぞれ年間15.8%と46.8%減少すると予測されています。EPS は年間46.4%で減少すると予想されています。自己資本利益率は 3 年後に2.1%になると予測されています。

主要情報

-46.8%

収益成長率

-46.4%

EPS成長率

Medical Equipment 収益成長	12.9%
収益成長率	-15.8%
将来の株主資本利益率	2.1%
アナリストカバレッジ	Low
最終更新日	02 Jan 2025

今後の成長に関する最新情報

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

Nov 08

Recent updates

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

Dec 11

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Nov 14

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

Nov 08

OraSure: An NCAV Diamond In The COVID Rough

Nov 04

OraSure Technologies: Nursing A COVID-19 Hangover

Sep 10

OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

May 11

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Apr 17

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Dec 20

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Nov 08

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Aug 09

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

May 16

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

May 13

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Feb 17

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Jun 14

業績と収益の成長予測

NasdaqGS:OSUR - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	155	-9	-1	3	5
12/31/2025	145	-16	1	4	5
12/31/2024	186	-13	26	31	5
9/30/2024	224	11	64	69	N/A
6/30/2024	274	27	86	93	N/A
3/31/2024	305	23	134	142	N/A
12/31/2023	405	54	131	142	N/A
9/30/2023	453	49	76	82	N/A
6/30/2023	480	44	50	62	N/A
3/31/2023	475	30	-25	-5	N/A
12/31/2022	387	-17	-111	-47	N/A
9/30/2022	328	-43	-129	-42	N/A
6/30/2022	265	-64	-162	-77	N/A
3/31/2022	243	-47	-152	-67	N/A
12/31/2021	234	-23	-83	-35	N/A
9/30/2021	233	-11	-62	-19	N/A
6/30/2021	227	5	-39	5	N/A
3/31/2021	199	-4	-36	-1	N/A
12/31/2020	172	-15	-23	6	N/A
9/30/2020	158	-14	-14	1	N/A
6/30/2020	146	-2	-9	3	N/A
3/31/2020	156	13	0	12	N/A
12/31/2019	155	17	0	10	N/A
9/30/2019	150	25	17	25	N/A
6/30/2019	159	20	22	30	N/A
3/31/2019	161	19	25	32	N/A
12/31/2018	182	20	33	39	N/A
9/30/2018	177	17	16	23	N/A
6/30/2018	174	15	N/A	20	N/A
3/31/2018	174	16	N/A	23	N/A
12/31/2017	166	31	N/A	28	N/A
9/30/2017	145	31	N/A	30	N/A
6/30/2017	135	31	N/A	30	N/A
3/31/2017	126	30	N/A	32	N/A
12/31/2016	123	20	N/A	25	N/A
9/30/2016	125	17	N/A	26	N/A
6/30/2016	123	12	N/A	36	N/A
3/31/2016	122	11	N/A	27	N/A
12/31/2015	120	8	N/A	16	N/A
9/30/2015	116	1	N/A	14	N/A
6/30/2015	114	1	N/A	15	N/A
3/31/2015	110	1	N/A	9	N/A
12/31/2014	106	-5	N/A	8	N/A
9/30/2014	107	4	N/A	20	N/A
6/30/2014	103	1	N/A	7	N/A
3/31/2014	101	-7	N/A	8	N/A

アナリストによる今後の成長予測

収入対貯蓄率: OSURの収益は今後 3 年間で減少すると予測されています (年間-46.8% )。

収益対市場: OSURの収益は今後 3 年間で減少すると予測されています (年間-46.8% )。

高成長収益: OSURの収益は今後 3 年間で減少すると予測されています。

収益対市場: OSURの収益は今後 3 年間で減少すると予想されています (年間-15.8% )。

高い収益成長: OSURの収益は今後 3 年間で減少すると予測されています (年間-15.8% )。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: OSURの自己資本利益率は、3年後には低くなると予測されています ( 2.1 %)。

成長企業の発掘

企業分析と財務データの現状

データ	最終更新日（UTC時間）
企業分析	2025/01/31 05:11
終値	2025/01/31 00:00
収益	2024/09/30
年間収益	2023/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用^。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

OraSure Technologies, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、。アナリストの投稿は一日中更新されます。17

アナリスト	機関
Charley Jones	Barrington Research Associates, Inc.
Karen Koski	BTIG
Mark Massaro	Canaccord Genuity

OraSure Technologies 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

OraSure Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024

Consensus EPS estimates upgraded to US$0.098 loss

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2024

Price target decreased by 7.5% to US$6.13

Consensus EPS estimates fall by 54%

Recent updates

Nowdiagnostics, Inc. Files Countersuit Against Frivolous Orasure Claims

OraSure Technologies, Inc.'s OraQuick HIV Self-Test Receives Approval for Use in Adolescents

OraSure Technologies, Inc. (NasdaqGS:OSUR) acquired Sherlock Biosciences, Inc. from a group of shareholders.

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

OraSure Technologies, Inc. Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test from Biomedical Advanced Research and Development Authority

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

OraSure Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024

New minor risk - Profit margin trend

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

OraSure: An NCAV Diamond In The COVID Rough

OraSure Technologies, Inc. to Report Q3, 2024 Results on Nov 06, 2024

OraSure Technologies, Inc. Appoints John P. Kenny as New Member of the Board, Member of the Nominating and Corporate Governance Committee

OraSure Technologies: Nursing A COVID-19 Hangover

Consensus EPS estimates upgraded to US$0.098 loss

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2024

OraSure Technologies, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target decreased by 7.5% to US$6.13

Consensus EPS estimates fall by 54%

Price target decreased by 7.9% to US$6.95

OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

New minor risk - Shareholder dilution

OraSure Technologies, Inc. Provides Revenue Guidance for the Second Quarter of 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

New minor risk - Shareholder dilution

OraSure Technologies, Inc., Annual General Meeting, May 14, 2024

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

New minor risk - Earnings quality

OraSure Technologies, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Full year 2023 earnings: EPS exceeds analyst expectations

OraSure Technologies, Inc. to Report Fiscal Year 2023 Results on Feb 27, 2024

Chief Product Officer notifies of intention to sell stock

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Investor sentiment improves as stock rises 18%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Financial Guidance for the Fourth Quarter 2023

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

OraSure Technologies, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investor sentiment improves as stock rises 41%

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2023

OraSure Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

OraSure Technologies, Inc. Announces Election of Robert W. McMahon to its Board of Directors, Effective July 31, 2023

Price target decreased by 7.2% to US$6.45

OraSure Technologies, Inc. Announces Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

Investor sentiment improves as stock rises 17%

Chief Financial Officer recently bought US$493k worth of stock

Investor sentiment deteriorates as stock falls 22%

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Price target increased by 13% to US$6.95

Orasure Technologies, Inc. Provides Earnings Guidance for the Second Quarter 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. to Report Q1, 2023 Results on May 10, 2023

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Price target increased by 8.0% to US$5.88

Full year 2022 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2023

OraSure Technologies, Inc. to Report Q4, 2022 Results on Feb 14, 2023

We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

Consensus estimates of losses per share improve by 69%

High number of new directors

OraSure Technologies, Inc. Announces Executive Changes

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations